- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07785570
Hamstring Versus Quadriceps Tendon Graft for MPFL Reconstruction
August 21, 2026 updated by: Mahmoud Ahmed El-Desouky, Cairo University
Comparison Between Hamstring Versus Quadriceps Tendon Graft in MPFL Reconstruction for Recurrent Patellar Dislocation
This prospective comparative study compared the clinical and radiological outcomes of medial patellofemoral ligament (MPFL) reconstruction using a hamstring tendon graft versus a quadriceps tendon graft in patients with recurrent patellar dislocation.
The study included 38 patients with 40 affected knees who underwent MPFL reconstruction using either a hamstring tendon graft or a quadriceps tendon graft, according to the treating surgeon's preference.
Patients were prospectively followed in two groups according to the graft used.
Clinical outcomes were assessed using the Kujala, International Knee Documentation Committee (IKDC), and Tegner-Lysholm scores.
Radiological assessment included patellar tilt angle and congruence angle.
Postoperative complications and recurrent patellar instability were also evaluated.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
38
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Cairo University Hospitals (Kasr Al-Ainy)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with recurrent patellar instability who underwent medial patellofemoral ligament reconstruction using either a hamstring tendon graft or a quadriceps tendon graft.
Description
Inclusion Criteria:
- Patients with recurrent patellar dislocation.
- Age from 18 to 40 years.
- Patients indicated for isolated medial patellofemoral ligament (MPFL) reconstruction.
Exclusion Criteria:
- Patients with trochlear dysplasia (Dejour B-C-D).
- Patients with clinical evidence of mal-alignment (varus, valgus, flat foot and femoral anteversion).
- Patients with congenital pateller dislocation.
- Patella alta and patella baja.
- Previous quadriceps muscles operation.
- Patients with patellofemoral OA.
- Patients with hypermobility syndrome.
- Patients with associated pathology.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Hamstring Tendon Graft Group
Patients who underwent MPFL reconstruction using a hamstring tendon graft.
|
Medial patellofemoral ligament reconstruction was performed using an autologous semitendinosus tendon graft.
The graft was fixed to the medial aspect of the patella and passed between layers 2 and 3 of the medial knee structures, followed by femoral fixation at the anatomical MPFL insertion.
|
|
Quadriceps Tendon Graft Group
Patients who underwent MPFL reconstruction using a quadriceps tendon graft.
|
Medial patellofemoral ligament reconstruction was performed using a distally based superficial quadriceps tendon graft.
The graft remained attached to the superior pole of the patella, was passed between layers 2 and 3 of the medial knee structures, and was fixed at the anatomical femoral insertion of the MPFL.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kujala score
Time Frame: 12 months postoperatively
|
Functional outcome assessed using the Kujala anterior knee pain scale.
The score ranges from 0 to 100, with higher scores indicating better knee function and fewer patellofemoral symptoms.
|
12 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
International Knee Documentation Committee (IKDC) Score
Time Frame: 12 months postoperatively
|
Knee function was assessed using the International Knee Documentation Committee (IKDC) score.
Scores range from 0 to 100, with higher scores indicating better knee function.
|
12 months postoperatively
|
|
Tegner-Lysholm Knee Score
Time Frame: 12 months postoperatively
|
Knee function was assessed using the Tegner-Lysholm knee score.
Scores range from 0 to 100, with higher scores indicating better knee function.
|
12 months postoperatively
|
|
Patellar Tilt Angle
Time Frame: 12 months postoperatively
|
Patellar tilt angle was measured radiologically to assess patellofemoral alignment before and after MPFL reconstruction.
|
12 months postoperatively
|
|
Congruence Angle
Time Frame: 12 months postoperatively
|
Congruence angle was measured radiologically to assess patellofemoral alignment before and after MPFL reconstruction.
|
12 months postoperatively
|
|
Incidence of Re-dislocation
Time Frame: 12 months postoperatively
|
Number of cases who experienced re-dislocation after MPFL reconstruction
|
12 months postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2018
Primary Completion (Actual)
June 1, 2022
Study Completion (Actual)
June 1, 2022
Study Registration Dates
First Submitted
August 21, 2026
First Submitted That Met QC Criteria
August 21, 2026
First Posted (Actual)
August 25, 2026
Study Record Updates
Last Update Posted (Actual)
August 25, 2026
Last Update Submitted That Met QC Criteria
August 21, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- N-356-2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.